LGBWB - Overview: Globotriaosylsphingosine, Blood

Screening of patients with Fabry disease when a serum specimen is not available This test should not be used for newborn screening followup.

EMICZ - Overview: Emicizumab, Modified One Stage Assay Factor VIII, Plasma

Monitoring compliance or potential development of an antidrug antibody This assay is not indicated for monitoring factor VIII infusions or for making a diagnosis of hemophilia.

INSFT - Overview: Insulin, Free and Total, Serum

Assessing free (bioactive) insulin concentrations in patients with known or suspected anti-insulin antibodies

MPLVS - Overview: MPL Exon 10 Mutation Detection, Varies

Aiding in the distinction between a reactive cytosis and a myeloproliferative neoplasm

OXYSU - Overview: Oxycodone Screen, Random, Urine

Detection of oxycodone and oxymorphone in urine

PNYA - Overview: Phenytoin, Total, Serum

Monitoring for appropriate therapeutic concentration Assessing compliance or toxicity

PRMB - Overview: Primidone and Phenobarbital, Serum

Assessing compliance Monitoring for appropriate therapeutic levels of primidone and phenobarbital Assessing toxicity

OXYCX - Overview: Oxycodone with Metabolite Confirmation, Chain of Custody, Random, Urine

Detection and quantification of oxycodone, oxymorphone, noroxycodone, and noroxymorphone in urine Chain of custody is required whenever the results of testing could be used in a court of law. Its purpose is to protect the rights of the...

IL5P - Overview: Interleukin 5, Plasma

Evaluation of patients with disorders known to be associated with hypereosinophilia

STICK - Overview: Tick-Borne Antibodies, Modified 2-Tier, ELISA, Serum

Evaluation of the most common tick-borne diseases found in the United States, including Lyme disease, human monocytic and granulocytic ehrlichiosis, and babesiosis using the modified 2-tier testing algorithm approach Evaluation of patients...